期刊簡介 | |||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名稱 | NUCLEAR MEDICINE AND BIOLOGY LetPub Score 6.2
50 ratings
Rate
Reputation 7.6 Influence 4.9 Speed 7.0 | ||||||||||||||||||||||||
期刊簡稱 | NUCL MED BIOL | ||||||||||||||||||||||||
ISSN | 0969-8051 | ||||||||||||||||||||||||
E-ISSN | 1872-9614 | ||||||||||||||||||||||||
h-index | 82 | ||||||||||||||||||||||||
CiteScore |
| ||||||||||||||||||||||||
自引率 (2023-2024) | 5.60%自引率趨勢 | ||||||||||||||||||||||||
掲載範囲 |
| ||||||||||||||||||||||||
官方網站 | http://www.journals.elsevier.com/nuclear-medicine-and-biology/ | ||||||||||||||||||||||||
在線稿件提交 | https://www.editorialmanager.com/NUCMEDBIO | ||||||||||||||||||||||||
開放訪問 | No | ||||||||||||||||||||||||
出版商 | Elsevier Inc. | ||||||||||||||||||||||||
主題領域 | 医学 | ||||||||||||||||||||||||
出版國/地區 | UNITED STATES | ||||||||||||||||||||||||
發行頻率 | 隔月刊行 | ||||||||||||||||||||||||
創刊年 | 1993 | ||||||||||||||||||||||||
每年文章數 | 38每年文章數趨勢 | ||||||||||||||||||||||||
黃金OA百分比 | 35.59% | ||||||||||||||||||||||||
Web of Science 四分位 ( 2023-2024) | WOS Quartile: Q1
| ||||||||||||||||||||||||
索引 (SCI or SCIE) | Science Citation Index Science Citation Index Expanded | ||||||||||||||||||||||||
鏈接到PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=0969-8051%5BISSN%5D | ||||||||||||||||||||||||
平均審稿時間 * | 來自出版商的數據: 來自作者的數據: Ordinary, 3-8 Week(s) 來自Elsevier的數據: Average 8 Week(s) | ||||||||||||||||||||||||
競爭力 * | 來自作者的數據: Easy | ||||||||||||||||||||||||
在線文章發布時間 | 來自Elsevier的數據: Average 6.7 Week(s) | ||||||||||||||||||||||||
參考鏈接 |
| ||||||||||||||||||||||||
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。 |
|
|
首頁 上一頁 1 下一頁 末頁 (頁 | |
[NUCLEAR MEDICINE AND BIOLOGY] 的評論 | 撰寫評論 |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 16:28:35 評論於 Keywords are often the words that appear most frequently in the text; Keywords are words that can represent the essence of your paper, making it easier to find and increasing the chances of citation(0) 讚! | 维尔娜菲茨杰拉德 |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 09:03:58 評論於 In the medical field, most journals and clinical papers specifically recommend MeSH. The use of MeSH terms is to assist in literature searching and increase the weight of publications(0) 讚! | 维尔娜菲茨杰拉德 |
作者: Oswald Edie 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-28 19:28:18 評論於 What are the requirements for keyword selection?(0) 讚! | Oswald Edie |
作者: 陶宜三岁啦 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-26 15:02:02 評論於 Why should we filter keywords from MeSH?(0) 讚! | 陶宜三岁啦 |
作者: 雅松可爱吗 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2017-12-27 10:42:37 評論於 Review speed: 1.0 | Submission success rate: 5.0 Experience sharing: Rejected after three days of submission(0) 讚! | 雅松可爱吗 |
作者: 凌霄高洁 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2017-07-18 21:47:58 評論於 Although there are no major changes this year, we will see in the future(0) 讚! | 凌霄高洁 |
作者: 匿名 領域: 医药科学 審稿時間: 0.0 month(s) 結果: 撰寫評論 |
2013-08-02 11:25:00 評論於 Very slow, only one reviewer.It is also very slow from reception to final publication, about two months.After submitting the manuscript to the end, it has basically passed for half a year.(0) 讚! | 匿名 |
作者: 北风滨海 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2013-08-02 08:24:37 評論於 Very slow, with only one reviewer. It also took a very long time from submission to final publication, about two months. It took almost half a year from submission to final publication(0) 讚! | 北风滨海 |
作者: 匿名 領域: 放射性药物 審稿時間: 0.0 month(s) 結果: 撰寫評論 |
2011-01-05 17:57:00 評論於 The old nuclear medicine journal focuses on radiochemical synthesis and biological evaluation. Although IF is not high, it is strict.(0) 讚! | 匿名 |
作者: 凌霄高洁 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2010-05-07 18:02:17 評論於 Entering under review status was quick, but the review time has been going on for three months now, and still no news. I've sent a reminder once, but still no response(0) 讚! | 凌霄高洁 |
首頁 上一頁 1 下一頁 末頁 (頁 |
Contact us